Home LiteratureArticle Details
PMID: 17497145 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

The spectrum of HLA-DQ and HLA-DR alleles, 2006: a listing correlating sequence and structure with function.

Immunogenetics ·Vol. 59 ·No. 7 ·2007-07-00 ·Pages 539-53

Bondinas GP, Moustakas AK, Papadopoulos GK

Abstract

The list of alleles in the HLA-DRB, HLA-DQA, and HLA-DQB gene loci has grown enormously since the last listing in this journal 8 years ago. Crystal structure determination of several human and mouse HLA class II alleles, representative of two gene loci in each species, enables a direct comparison of ortholog and paralog loci. A new numbering system is suggested, extending earlier suggestions by [Fremont et al. in Immunity 8:305-317, (1998)], which will bring in line all the structural features of various gene loci, regardless of animal species. This system allows for structural equivalence of residues from different gene loci. The listing also highlights all amino acid residues participating in the various functions of these molecules, from antigenic peptide binding to homodimer formation, CD4 binding, membrane anchoring, and cytoplasmic signal transduction, indicative of the variety of functions of these molecules. It is remarkable that despite the enormous number of unique alleles listed thus far (DQA = 22, DQB = 54, DRA = 2, and DRB = 409), there is invariance at many specific positions in man, but slightly less so in mouse or rat, despite their much lower number of alleles at each gene locus in the latter two species. Certain key polymorphisms (from substitutions to an eight-residue insertion in the cytoplasmic tail of certain DQB alleles) that have thus far gone unnoticed are highly suggestive of differences or diversities in function and thus call for further investigation into the properties of these specific alleles. This listing is amenable to supplementation by future additions of new alleles and the highlighting of new functions to be discovered, providing thus a unifying platform of reference in all animal species for the MHC class II allelic counterparts, aiding research in the field and furthering our understanding of the functions of these molecules.

MeSH Terms
Alleles Amino Acid Sequence Animals Dimerization H-2 Antigens/chemistry,genetics,physiology HLA-DQ Antigens/chemistry,genetics,physiology HLA-DR Antigens/chemistry,genetics,physiology Humans Mice Molecular Sequence Data Polymorphism, Genetic Protein Structure, Tertiary/genetics Sequence Analysis, Protein Structure-Activity Relationship
Chemicals
H-2 Antigens H-2A antigen H-2E(k) antigen HLA-DQ Antigens HLA-DR Antigens
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Bondinas George P
Laboratory of Biochemistry and Biophysics, Faculty of Agricultural Technology, Epirus Institute of Technology, GR47100 Arta, Greece.
Moustakas Antonis K
Papadopoulos George K
References (117)
117 references, click to expand
  1. HLA class II-induced translocation of PKC alpha and PKC beta II isoforms is abrogated following truncation of DR beta cytoplasmic domains.
    J Immunol. 1997 Oct 15;159(8):3792-8 PMID: 9378966
  2. X-ray crystal structure of HLA-DR4 (DRA*0101, DRB1*0401) complexed with a peptide from human collagen II.
    Immunity. 1997 Oct;7(4):473-81 PMID: 9354468
  3. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes.
    Nat Immunol. 2001 Jun;2(6):501-7 PMID: 11376336
  4. Structure of a human autoimmune TCR bound to a myelin basic protein self-peptide and a multiple sclerosis-associated MHC class II molecule.
    EMBO J. 2005 Sep 7;24(17):2968-79 PMID: 16079912
  5. A functional and structural basis for TCR cross-reactivity in multiple sclerosis.
    Nat Immunol. 2002 Oct;3(10):940-3 PMID: 12244309
  6. The orientation of a T cell receptor to its MHC class II:peptide ligands.
    J Immunol. 1997 Nov 1;159(9):4395-402 PMID: 9379037
  7. Alternate interactions define the binding of peptides to the MHC molecule IA(b).
    Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8820-5 PMID: 12084926
  8. Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules.
    Nature. 1992 Apr 30;356(6372):799-801 PMID: 1574119
  9. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1.
    Nature. 1993 Jul 1;364(6432):33-9 PMID: 8316295
  10. The wide diversity and complexity of peptides bound to class II MHC molecules.
    Curr Opin Immunol. 2006 Feb;18(1):70-7 PMID: 16316750
  11. Involvement of both major histocompatibility complex class II alpha and beta chains in CD4 function indicates a role for ordered oligomerization in T cell activation.
    J Exp Med. 1995 Sep 1;182(3):779-87 PMID: 7650484
  12. Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice.
    Immunity. 2000 Jun;12(6):699-710 PMID: 10894169
  13. Large-scale sequence comparisons reveal unusually high levels of variation in the HLA-DQB1 locus in the class II region of the human MHC.
    J Mol Biol. 1998 Sep 11;282(1):71-97 PMID: 9733642
  14. A hypothetical model of the foreign antigen binding site of class II histocompatibility molecules.
    Nature. 1988 Apr 28;332(6167):845-50 PMID: 3258651
  15. Immunological properties of the thymopentin-like fragments of HLA-DQ.
    Mol Immunol. 1996 Aug;33(11-12):903-8 PMID: 8960113
  16. Allelic variation in transcription modulates MHC class II expression and function.
    Microbes Infect. 1999 Sep;1(11):919-27 PMID: 10614010
  17. Biochemical characterization of proteins that co-purify with class II antigens of the murine MHC.
    J Immunol. 1988 Mar 15;140(6):1930-8 PMID: 3162251
  18. The immunological synapse: a molecular machine controlling T cell activation.
    Science. 1999 Jul 9;285(5425):221-7 PMID: 10398592
  19. Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium.
    Nature. 1999 Oct 28;401(6756):921-3 PMID: 10553908
  20. Trafficking of MHC class II molecules in the late secretory pathway.
    Curr Opin Immunol. 2002 Feb;14(1):30-5 PMID: 11790530
  21. A role for the transmembrane domain in the trimerization of the MHC class II-associated invariant chain.
    J Immunol. 1999 Sep 1;163(5):2704-12 PMID: 10453012
  22. Nucleotide sequence, polymorphism, and evolution of ovine MHC class II DQA genes.
    Immunogenetics. 1991;34(2):69-79 PMID: 1678367
  23. MHC class II molecules that lack cytoplasmic domains are associated with the cytoskeleton.
    J Immunol. 1994 Oct 15;153(8):3398-407 PMID: 7930565
  24. Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy.
    Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1999-2004 PMID: 14769912
  25. Solution structure of human CTLA-4 and delineation of a CD80/CD86 binding site conserved in CD28.
    Nat Struct Biol. 1997 Jul;4(7):527-31 PMID: 9228944
  26. Crystal structure of I-Ak in complex with a dominant epitope of lysozyme.
    Immunity. 1998 Mar;8(3):305-17 PMID: 9529148
  27. Structure and evolution of the promoter regions of the DQA genes.
    Immunogenetics. 1993;37(5):364-72 PMID: 8428769
  28. T Cell Receptor Binding to a pMHCII Ligand Is Kinetically Distinct from and Independent of CD4.
    J Biol Chem. 2001 Feb 23;276(8):5659-67 PMID: 11106664
  29. Distinct structural compartmentalization of the signal transducing functions of major histocompatibility complex class II (Ia) molecules.
    J Exp Med. 1994 Feb 1;179(2):763-8 PMID: 8294884
  30. Molecular basis for HLA-DQ associations with IDDM.
    Diabetes. 1998 Aug;47(8):1177-84 PMID: 9703314
  31. A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes.
    Science. 2000 Apr 21;288(5465):505-11 PMID: 10775108
  32. MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8.
    Nature. 1992 Apr 30;356(6372):796-8 PMID: 1574118
  33. MHC ligands and peptide motifs: first listing.
    Immunogenetics. 1995;41(4):178-228 PMID: 7890324
  34. Identification of the lateral interaction surfaces of human histocompatibility leukocyte antigen (HLA)-DM with HLA-DR1 by formation of tethered complexes that present enhanced HLA-DM catalysis.
    J Exp Med. 2002 Jul 15;196(2):173-83 PMID: 12119342
  35. The tetraspan protein CD82 is a resident of MHC class II compartments where it associates with HLA-DR, -DM, and -DO molecules.
    J Immunol. 1998 Oct 1;161(7):3282-91 PMID: 9759843
  36. The immune function of MHC class II molecules mutated in the putative superdimer interface.
    Mol Cell Biochem. 2005 May;273(1-2):1-9 PMID: 16013435
  37. Polymorphic structural features of modelled HLA-DQ molecules segregate according to susceptibility or resistance to IDDM.
    Diabetologia. 1995 Nov;38(11):1251-61 PMID: 8582533
  38. Structure of a covalently stabilized complex of a human alphabeta T-cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1.
    EMBO J. 2000 Nov 1;19(21):5611-24 PMID: 11060013
  39. Truncation of the class II beta-chain cytoplasmic domain influences the level of class II/invariant chain-derived peptide complexes.
    Proc Natl Acad Sci U S A. 1996 Jan 9;93(1):241-4 PMID: 8552613
  40. Not just any T cell receptor will do.
    Immunity. 2003 Jan;18(1):7-11 PMID: 12530971
  41. A molecular basis for MHC class II--associated autoimmunity.
    Science. 1988 May 20;240(4855):1003-9 PMID: 3368786
  42. Ancestral major histocompatibility complex DRB genes beget conserved patterns of localized polymorphisms.
    Proc Natl Acad Sci U S A. 1996 May 28;93(11):5380-3 PMID: 8643583
  43. Novel structural features of the human histocompatibility molecules HLA-DQ as revealed by modeling based on the published structure of the related molecule HLA-DR.
    J Struct Biol. 1996 Sep-Oct;117(2):145-63 PMID: 8931340
  44. Potent T cell activation with dimeric peptide-major histocompatibility complex class II ligand: the role of CD4 coreceptor.
    J Exp Med. 1998 Nov 2;188(9):1633-40 PMID: 9802975
  45. Structure of a trimeric domain of the MHC class II-associated chaperonin and targeting protein Ii.
    EMBO J. 1998 Dec 1;17(23):6812-8 PMID: 9843486
  46. Greek Cypriot allele and genotype frequencies for Amplitype PM-DQA1 and D1S80 loci.
    J Forensic Sci. 1998 May;43(3):661-4 PMID: 9608705
  47. Disruption of the CD4-major histocompatibility complex class II interaction blocks the development of CD4(+) T cells in vivo.
    Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4493-8 PMID: 9539765
  48. Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein.
    J Exp Med. 1998 Oct 19;188(8):1511-20 PMID: 9782128
  49. Interactions between MHC molecules and co-receptors of the TCR.
    Curr Opin Immunol. 2002 Feb;14(1):75-83 PMID: 11790535
  50. Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer.
    J Exp Med. 1989 Jan 1;169(1):345-50 PMID: 2909659
  51. Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus.
    Diabetologia. 1993 May;36(5):371-7 PMID: 8314439
  52. Structure of celiac disease-associated HLA-DQ8 and non-associated HLA-DQ9 alleles in complex with two disease-specific epitopes.
    Int Immunol. 2000 Aug;12 (8):1157-66 PMID: 10917890
  53. Ligand-specific oligomerization of T-cell receptor molecules.
    Nature. 1997 Jun 5;387(6633):617-20 PMID: 9177351
  54. A role for MHC class II antigens in B-cell activation.
    J Autoimmun. 1989 Jun;2 Suppl:215-23 PMID: 2789060
  55. Structures of an MHC class II molecule with covalently bound single peptides.
    Science. 1996 May 17;272(5264):1001-4 PMID: 8638119
  56. Mutational analysis of critical residues determining antigen presentation and activation of HLA-DQ0602 restricted T-cell clones.
    Hum Immunol. 2002 Mar;63(3):185-93 PMID: 11872236
  57. Molecular properties of HLA-DQ alleles conferring susceptibility to or protection from insulin-dependent diabetes mellitus: keys to the fate of islet beta-cells.
    Am J Med Genet. 2002 May 30;115(1):37-47 PMID: 12116175
  58. Structure of an autoimmune T cell receptor complexed with class II peptide-MHC: insights into MHC bias and antigen specificity.
    Immunity. 2005 Jan;22(1):81-92 PMID: 15664161
  59. Peripheral expression of self-MHC-II influences the reactivity and self-tolerance of mature CD4(+) T cells: evidence from a lymphopenic T cell model.
    Immunity. 2002 Oct;17(4):425-36 PMID: 12387737
  60. CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins.
    Eur J Immunol. 1996 Nov;26(11):2657-65 PMID: 8921952
  61. Structure of a complex of the human alpha/beta T cell receptor (TCR) HA1.7, influenza hemagglutinin peptide, and major histocompatibility complex class II molecule, HLA-DR4 (DRA*0101 and DRB1*0401): insight into TCR cross-restriction and alloreactivity.
    J Exp Med. 2002 Mar 4;195(5):571-81 PMID: 11877480
  62. Immunological suppression by human CD8+ T cells is receptor dependent and HLA-DQ restricted.
    Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2598-602 PMID: 1826057
  63. The specificity of TCR/pMHC interaction.
    Curr Opin Immunol. 2002 Feb;14(1):52-65 PMID: 11790533
  64. The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation.
    Immunity. 1998 Sep;9(3):377-83 PMID: 9768757
  65. Differential clustering of CD4 and CD3zeta during T cell recognition.
    Science. 2000 Aug 25;289(5483):1349-52 PMID: 10958781
  66. Monocytes are differentially activated through HLA-DR, -DQ, and -DP molecules via mitogen-activated protein kinases.
    J Immunol. 2001 Feb 15;166(4):2202-8 PMID: 11160273
  67. The CD28 ligand B7/BB1 provides costimulatory signal for alloactivation of CD4+ T cells.
    J Exp Med. 1991 Mar 1;173(3):759-62 PMID: 1847724
  68. MHC class II proteins and disease: a structural perspective.
    Nat Rev Immunol. 2006 Apr;6(4):271-82 PMID: 16557259
  69. The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class II oligomers.
    Immunity. 2000 Mar;12(3):241-50 PMID: 10755611
  70. Genomic organization of the mammalian MHC.
    Annu Rev Immunol. 2003;21:629-57 PMID: 12500978
  71. Genetics of demyelinating diseases.
    Brain Pathol. 1996 Jul;6(3):289-302 PMID: 8864285
  72. Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses.
    Nature. 2001 Mar 29;410(6828):608-11 PMID: 11279502
  73. The lysosomal cysteine proteases in MHC class II antigen presentation.
    Immunol Rev. 2005 Oct;207:229-41 PMID: 16181340
  74. Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule.
    Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10799-804 PMID: 11535811
  75. HLA informatics. Accessing HLA sequences from sequence databases.
    Methods Mol Biol. 2003;210:3-21 PMID: 12412448
  76. HLA-D and -DR antigens in genetic analysis of insulin dependent diabetes mellitus.
    Diabetologia. 1981 Aug;21(2):108-15 PMID: 6167481
  77. Amino acid substitutions in the putative MHC class II "dimer of dimers" interface inhibit CD4+ T cell activation.
    J Immunol. 2001 Jan 15;166(2):800-8 PMID: 11145653
  78. Altered TCR signaling from geometrically repatterned immunological synapses.
    Science. 2005 Nov 18;310(5751):1191-3 PMID: 16293763
  79. Regulation of memory CD4 T cell adhesion by CD4-MHC class II interaction.
    J Immunol. 1997 Sep 15;159(6):2567-73 PMID: 9300674
  80. Immunosuppressory mini-regions of HLA-DP and HLA-DR.
    Mol Immunol. 1999 Jun;36(8):525-33 PMID: 10475607
  81. Structural snapshot of aberrant antigen presentation linked to autoimmunity: the immunodominant epitope of MBP complexed with I-Au.
    Immunity. 2002 Jul;17(1):83-94 PMID: 12150894
  82. Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides.
    Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):734-8 PMID: 8570625
  83. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins.
    J Mol Biol. 2000 Nov 24;304(2):177-88 PMID: 11080454
  84. Allelic polymorphism in transcriptional regulatory regions of HLA-DQB genes.
    J Exp Med. 1991 Jan 1;173(1):181-92 PMID: 1985121
  85. Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination.
    Nature. 2006 Nov 2;444(7115):115-8 PMID: 17051151
  86. RGD sequences in several receptor proteins: novel cell adhesion function of receptors?
    Int J Biol Macromol. 1998 Feb;22(1):51-7 PMID: 9513816
  87. Clustering of MHC-peptide complexes prior to their engagement in the immunological synapse: lipid raft and tetraspan microdomains.
    Immunol Rev. 2002 Nov;189:136-51 PMID: 12445271
  88. HLA-DQ allelic polymorphisms constrain patterns of class II heterodimer formation.
    J Immunol. 1993 Mar 15;150(6):2263-72 PMID: 8450211
  89. The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3.
    Nature. 1995 Nov 30;378(6556):457-62 PMID: 7477400
  90. Requirement for efficient interactions between CD4 and MHC class II molecules for survival of resting CD4+ T lymphocytes in vivo and for activation-induced cell death.
    J Immunol. 1999 May 15;162(10):5973-80 PMID: 10229835
  91. The role of class II molecules in human B cell activation. Association with phosphatidyl inositol turnover, protein tyrosine phosphorylation, and proliferation.
    J Immunol. 1990 May 15;144(10):3684-92 PMID: 1692059
  92. Crystal structure of MHC class II I-Ab in complex with a human CLIP peptide: prediction of an I-Ab peptide-binding motif.
    J Mol Biol. 2003 Feb 28;326(4):1157-74 PMID: 12589760
  93. Integrins: versatility, modulation, and signaling in cell adhesion.
    Cell. 1992 Apr 3;69(1):11-25 PMID: 1555235
  94. A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus.
    J Clin Invest. 1990 Apr;85(4):1315-9 PMID: 2318983
  95. Association of distinct tetraspanins with MHC class II molecules at different subcellular locations in human immature dendritic cells.
    Int Immunol. 2001 Feb;13(2):127-34 PMID: 11157846
  96. The TAPA-1 molecule is associated on the surface of B cells with HLA-DR molecules.
    J Immunol. 1993 Oct 15;151(8):4090-7 PMID: 8409388
  97. Inhibition of MHC class II expression and immune responses by c-MIR.
    J Immunol. 2006 Jul 1;177(1):341-54 PMID: 16785530
  98. Unconventional topology of self peptide-major histocompatibility complex binding by a human autoimmune T cell receptor.
    Nat Immunol. 2005 May;6(5):490-6 PMID: 15821740
  99. Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity.
    J Clin Invest. 2005 Aug;115(8):2268-76 PMID: 16075062
  100. The peptide binding motif of the disease associated HLA-DQ (alpha 1* 0501, beta 1* 0201) molecule.
    Eur J Immunol. 1996 Nov;26(11):2764-72 PMID: 8921967
  101. Immunological synapses are versatile structures enabling selective T cell polarization.
    Immunity. 2005 Feb;22(2):185-94 PMID: 15723807
  102. Distinct ligand preferences of Src homology 3 domains from Src, Yes, Abl, Cortactin, p53bp2, PLCgamma, Crk, and Grb2.
    Proc Natl Acad Sci U S A. 1996 Feb 20;93(4):1540-4 PMID: 8643668
  103. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide.
    Nature. 1994 Mar 17;368(6468):215-21 PMID: 8145819
  104. Novel SLA-DQ alleles and their recombinant molecules in xenogeneic stimulation of human T cells.
    Transpl Immunol. 2005 Jun;14(2):83-9 PMID: 15935298
  105. Unique peptide binding characteristics of the disease-associated DQ(alpha 1*0501, beta 1*0201) vs the non-disease-associated DQ(alpha 1*0201, beta 1*0202) molecule.
    Immunogenetics. 1997;46(6):484-92 PMID: 9321428
  106. Modelling of the MHC II allele I-A(g7) of NOD mouse: pH-dependent changes in specificity at pockets 9 and 6 explain several of the unique properties of this molecule.
    Diabetologia. 2000 May;43(5):609-24 PMID: 10855536
  107. Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues.
    Immunity. 1998 Mar;8(3):319-29 PMID: 9529149
  108. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease.
    Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4175-9 PMID: 15020763
  109. The class II MHC protein HLA-DR1 in complex with an endogenous peptide: implications for the structural basis of the specificity of peptide binding.
    Structure. 1997 Oct 15;5(10):1385-96 PMID: 9351812
  110. Open reading frame sequencing and structure-based alignment of polypeptides encoded by RT1-Bb, RT1-Ba, RT1-Db, and RT1-Da alleles.
    Immunogenetics. 2004 Nov;56(8):585-96 PMID: 15517241
  111. Type 1 diabetes in Japan.
    Diabetologia. 2006 May;49(5):828-36 PMID: 16568259
  112. Crystallographic structure of a rheumatoid arthritis MHC susceptibility allele, HLA-DR1 (DRB1*0101), complexed with the immunodominant determinant of human type II collagen.
    J Immunol. 2006 Sep 15;177(6):3884-92 PMID: 16951351
  113. Signaling in the immunological synapse: defining the optimal size.
    Immunity. 2006 Jul;25(1):11-3 PMID: 16860751
  114. The cytoplasmic tail of invariant chain modulates antigen processing and presentation.
    Eur J Immunol. 2003 Feb;33(2):277-86 PMID: 12548558
  115. The crystal structure of a T cell receptor in complex with peptide and MHC class II.
    Science. 1999 Dec 3;286(5446):1913-21 PMID: 10583947
  116. The T cell receptor for antigen: signaling and ligand discrimination.
    J Biol Chem. 2001 Sep 21;276(38):35223-6 PMID: 11435448
  117. HLA-DQ is epistatic to HLA-DR in controlling the immune response to schistosomal antigen in humans.
    Nature. 1987 Jun 4-10;327(6121):426-30 PMID: 3108669
Article Info
Journal
Immunogenetics
Abbr.
Immunogenetics
ISSN
0093-7711
Published
2007-07-00
Epub
2007-00-12
Pages
539-53
Language
English
Region
United States
NLM ID
0420404
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]